aTyr Pharma Inc. (LIFE)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
03 Jun 2024 |
COUGHLIN TIMOTHY |
Director |
30 May 2024 |
50,000 |
1.75 |
87,500 |
03 Jun 2024 |
BROADFOOT JILL MARIE |
Chief Financial Officer |
31 May 2024 |
5,000 |
1.79 |
8,950 |
03 Jun 2024 |
SHUKLA SANJAY |
President and CEO |
31 May 2024 |
20,000 |
1.81 |
36,140 |
12 Dec 2023 |
SHUKLA SANJAY |
President and CEO |
12 Dec 2023 |
12,000 |
1.18 |
14,136 |
12 Dec 2023 |
SHUKLA SANJAY |
President and CEO |
11 Dec 2023 |
3,000 |
1.17 |
3,510 |
13 Nov 2023 |
SHUKLA SANJAY |
President and CEO |
13 Nov 2023 |
13,578 |
1.11 |
15,085 |
13 Nov 2023 |
SHUKLA SANJAY |
President and CEO |
10 Nov 2023 |
1,422 |
1.14 |
1,618 |
01 Aug 2023 |
SHUKLA SANJAY |
President and CEO |
28 Jul 2023 |
15,000 |
2.01 |
30,224 |
11 May 2023 |
SCHIMMEL PAUL |
Director |
10 May 2023 |
200,000 |
2.25 |
450,000 |
21 Nov 2022 |
SHUKLA SANJAY |
President and CEO |
21 Nov 2022 |
10,000 |
2.14 |
21,405 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock